AACR Round-Up: BMS, Lilly, iTeos, Affimed, Treovir, Revolution And Cardiff

Immuno-Oncology Highlights Include TIGIT, NK Cell Booster & HSV Oncolytic

Cancer cell 3D
Immunotherapy boosters, an oncolytic HSV therapy and other novel therapies were presented at AACR • Source: Shutterstock

More from Clinical Trials

More from R&D